Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Orthofix Medical (OFIX) Other Operating Expenses (2016 - 2026)

Orthofix Medical has reported Other Operating Expenses over the past 15 years, most recently at $2.9 million for Q1 2026.

  • For the quarter ending Q1 2026, Other Operating Expenses fell 4.14% year-over-year to $2.9 million, compared with a TTM value of -$33.9 million through Mar 2026, down 126.27%, and an annual FY2025 reading of -$33.8 million, down 114.25% over the prior year.
  • Other Operating Expenses came in at $2.9 million for Q1 2026, up from -$62.4 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $101.6 million in Q4 2022 to a low of -$62.4 million in Q4 2025.
  • Median Other Operating Expenses over the past 5 years was $1.3 million (2023), compared with a mean of -$2.0 million.
  • The sharpest move saw Other Operating Expenses soared 4863.84% in 2023, then crashed 139.22% in 2025.
  • Over 5 years, Other Operating Expenses stood at $101.6 million in 2022, then plummeted by 119.75% to -$20.1 million in 2023, then crashed by 30.02% to -$26.1 million in 2024, then plummeted by 139.22% to -$62.4 million in 2025, then skyrocketed by 104.67% to $2.9 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Other Operating Expenses are $2.9 million (Q1 2026), -$62.4 million (Q4 2025), and $21.5 million (Q3 2025).